Data Composite

Drug Recalls

Recent drug recall reports from the FDA (US) and Health Canada, newest first. Each entry links to the full record -- product description, reason for recall, and severity classification -- refreshed daily.

Dr. Reddy's Laboratories, Inc.

US Class II Ongoing · initiated 2024-10-09

CGMP Deviations: Presence of N-nitroso Cinacalcet impurity above FDA recommended interim limit

Dr. Reddy's Laboratories, Inc.

US Class II Ongoing · initiated 2024-10-09

CGMP Deviations: Presence of N-nitroso Cinacalcet impurity above FDA recommended interim limit

Dr. Reddy's Laboratories, Inc.

US Class II Ongoing · initiated 2024-10-09

CGMP Deviations: Presence of N-nitroso Cinacalcet impurity above FDA recommended interim limit

C & A Naturistics

US Class II Ongoing · initiated 2024-10-08

Marketed without an Approved NDA/ANDA: FDA analysis found the product to be tainted with undeclared diclofenac and acetaminophen.

Neogen Corporation

US Class II Ongoing · initiated 2024-10-08

CGMP violations.

Neogen Corporation

US Class II Ongoing · initiated 2024-10-08

CGMP violations.

Love Bites & Spanish Fly male / female sensual gummies

Canada Type II Ongoing · initiated 2024-10-07

Unauthorized product. Verify if your product is affected.Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any heal…

ACCORD HEALTHCARE, INC.

US Class II Terminated · initiated 2024-10-01

Failed Impurities/Degradation Specifications.

Glenmark Pharmaceuticals Inc., USA

US Class III Ongoing · initiated 2024-09-30

Defective Container: Firm received complaints of broken tube at the seal.

Staska Pharmaceuticals, Inc.

US Class I Terminated · initiated 2024-09-30

Presence of Particulate Matter: Presence of glass particulates.

M-Eslon capsule

Canada Type I Ongoing · initiated 2024-09-27

Labelling. Check your M-Eslon (morphine sulfate) medication bottle or package. If your prescription is for 30 mg, the capsules should be pink and clear. If it c…

Mint-Risperidon 0.25 mg tablet

Canada Type II Ongoing · initiated 2024-09-27

Product quality. Verify if your product is affected.Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health co…

Fresenius Kabi Compounding, LLC

US Class II Terminated · initiated 2024-09-25

cGMP violations

Fresenius Kabi Compounding, LLC

US Class II Terminated · initiated 2024-09-25

cGMP violations

Fresenius Kabi Compounding, LLC

US Class II Terminated · initiated 2024-09-25

cGMP violations

Fresenius Kabi Compounding, LLC

US Class II Terminated · initiated 2024-09-25

cGMP violations

Fresenius Kabi Compounding, LLC

US Class II Terminated · initiated 2024-09-25

cGMP violations

Fresenius Kabi Compounding, LLC

US Class II Terminated · initiated 2024-09-25

cGMP violations

Fresenius Kabi Compounding, LLC

US Class II Terminated · initiated 2024-09-25

cGMP violations

Fresenius Kabi Compounding, LLC

US Class II Terminated · initiated 2024-09-25

cGMP violations

Fresenius Kabi Compounding, LLC

US Class II Terminated · initiated 2024-09-25

CGMP violations

Fresenius Kabi Compounding, LLC

US Class II Terminated · initiated 2024-09-25

cGMP violations

Denison Pharmaceuticals, LLC

US Class III Ongoing · initiated 2024-09-25

Crystallization: Lack of uniformity - a change in texture, chunky, grainy, and small crystal substances inside the bottles.

Denison Pharmaceuticals, LLC

US Class III Ongoing · initiated 2024-09-25

Crystallization: Lack of uniformity - a change in texture, chunky, grainy, and small crystal substances inside the bottles.

Cromolyn eye drops

Canada Type II Ongoing · initiated 2024-09-25

Product quality. Do not use the affected product. Return it to your local pharmacy for proper disposal.Consult a health care professional if you have used this …